An upsurge in demand for 3D cell culture enabled market players to opt for various strategies to cater the worldwide demand in different sectors.
An upsurge in demand for 3D cell culture enabled market players to opt for various strategies to cater the worldwide demand in different sectors. Raising funding and collaboration with other players are two major strategies adopted by market players. Newly-raised funding will be utilized for growing the market presence in different regions along with increasing the market share. Moreover, the collaboration strategy is adopted for offering improved solutions by taking expertise of both companies into consideration. These strategies will be continued to adopt in the coming years. According to the report published by Allied Market Research, the global 3D cell culture market is projected to generate $3.72 billion by 2027. Following are some of the activities taking place across the world.
Market players have been taking different initiatives to expand its footprint and raise their market share across the world. Inventia Life Science, the Australian firm focused on development of advanced 3D cell culture, raised $25 million in funding. The funding round was led by Blackbird Ventures. The newly-raised funding will enable the company to scale up its RASTRUM 3D cell culture platform across the world and recruit new team members. The company has been focused on strengthening its presence across the U.S. market. This funding will be utilized for developing the product and go-to-market team in the country.
Want to Explore More Statistics and Industry Segments- https://www.alliedmarketresearch.com/request-sample/1474
The company will consolidate its partnership with academic customers and pharmaceutical players. It outlined that nearly 20 universities across the U.S., Australia, and Europe have been using the platform. It stated that there has been growing interest from contract research organizations and drug discovery companies for its platform. Such investments would help in raising the international presence and overall stake in the market.
Collaboration is another strategy taken by market players to address the growing demand for 3D cell culture market. Cellbox Solutions GmbH launched a new product CBS Naturally-3D Kit and collaborated with UPM Biomedicals for offering animal-free and plant-based shipping solutions. With the demand for 3D cell cultures and the requirement to take the forward-looking approach, the companies are offering environmental-friendly product to customers. Both companies have been collaborated to set new standards in live cell transport and shipping by launching the CBS Naturally-3D kit. Along with establishing an innovative transport technology for living cells, both companies aim to utilize expertise of each other to raise stakes in the market and gain international presence.